Schaller MD - Search Results

1

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

Robatel C, Decosterd LA, Biollaz J, Eckert P, Schaller MD, Buclin T. Robatel C, et al. Among authors: schaller md. J Clin Pharmacol. 2003 Dec;43(12):1329-40. doi: 10.1177/0091270003260286. J Clin Pharmacol. 2003. PMID: 14615469 Clinical Trial.

2

Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.

Robatel C, Buclin T, Eckert P, Schaller MD, Biollaz J, Decosterd LA. Robatel C, et al. Among authors: schaller md. J Pharm Biomed Anal. 2002 Jun 20;29(1-2):17-33. doi: 10.1016/s0731-7085(02)00022-5. J Pharm Biomed Anal. 2002. PMID: 12062661

3

Life-threatening asthma with dramatic resolution.

Wasserfallen JB, Schaller MD, Perret CH. Wasserfallen JB, et al. Among authors: schaller md. Chest. 1993 Aug;104(2):616-8. doi: 10.1378/chest.104.2.616. Chest. 1993. PMID: 8339657

4

Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.

Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F. Broccard A, et al. Among authors: schaller md. Shock. 2000 Jul;14(1):35-40. doi: 10.1097/00024382-200014010-00007. Shock. 2000. PMID: 10909891

5

Impact of the reduction of the recommended energy target in the ICU on protein delivery and clinical outcomes.

Berger MM, Soguel L, Charrière M, Thériault B, Pralong F, Schaller MD. Berger MM, et al. Among authors: schaller md. Clin Nutr. 2017 Feb;36(1):281-287. doi: 10.1016/j.clnu.2015.12.002. Epub 2015 Dec 28. Clin Nutr. 2017. PMID: 26775753

6

Anaphylactoid purpura like vasculitis following fibrinolytic therapy: role of the immune response to streptokinase.

Lantin JP, Gattesco S, Duclos A, Zanchi A, Schaller MD, Pecoud A, Aubert V. Lantin JP, et al. Among authors: schaller md. Clin Exp Rheumatol. 1994 Jul-Aug;12(4):429-33. Clin Exp Rheumatol. 1994. PMID: 7955610

7

Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock.

Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F. Liaudet L, et al. Among authors: schaller md. J Infect Dis. 1998 Jan;177(1):127-32. doi: 10.1086/513813. J Infect Dis. 1998. PMID: 9419179

8

Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement.

Maillard I, Schweizer V, Broccard A, Duscher A, Liaudet L, Schaller MD. Maillard I, et al. Among authors: schaller md. Chest. 2000 Sep;118(3):874-7. doi: 10.1378/chest.118.3.874. Chest. 2000. PMID: 10988221

9

Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.

Laurent T, Markert M, Feihl F, Schaller MD, Perret C. Laurent T, et al. Among authors: schaller md. Chest. 1996 Jan;109(1):163-6. doi: 10.1378/chest.109.1.163. Chest. 1996. PMID: 8549180 Clinical Trial.

10

[Emergency medicine for the practitioner: shock].

Schaller MD, Brinkley B. Schaller MD, et al. Rev Med Suisse Romande. 1997 Apr;117(4):321-4. Rev Med Suisse Romande. 1997. PMID: 9281030 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results